Abiopharma

🔍 Clum Brent W. (Executive)

Company: TXO Partners, L.P. (TXO)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Sold 27,234 shares of Common Units at $12.38 per share (Direct)
  Date: 2026-04-01 | Code: S | equity_swap_involved: false | shares_owned_after: 800,340.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents units sold to satisfy tax withholding obligations incident to the vesting of certain equity awards. This sale is covered under a Rule 10b5-1 trading arrangement. This sale is mandated by the Issuer's policy requiring satisfaction of tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
• REMARKS: The Reporting Person is Co-Chief Executive Officer and Chief Financial Officer and a director of TXO GP, LLC, the general partner of the Issuer (the "General Partner"). The Issuer is managed by the directors and executive officers of the General Partner.